Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Germ cell tumors.

Arif Hussain1

  • 1Department of Medicine, University of Maryland School of Medicine, University of Maryland Cancer Center, and The Baltimore VA Medical Center, Baltimore, Maryland, USA. ahussain@som.umaryland.edu

Current Opinion in Oncology
|April 9, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proteomic and glycosylation biomarkers in rheumatoid arthritis: advancing early diagnosis and precision therapy.

Clinical proteomics·2026
Same author

Patient-reported outcomes in castration-resistant prostate cancer with bone metastases treated with radium-223 with or without olaparib.

Cancer·2026
Same author

Pinocembrin, an anticancer dihydroxyflavanone: from chemistry to cellular interactions and synergistic prospects.

Cancer cell international·2026
Same author

Localized Tacrolimus Delivery for Peripheral Nerve Regeneration: Molecular Mechanisms, Biomaterial Platforms, and Translational Strategies.

International journal of molecular sciences·2026
Same author

Unveiling the anti-cancer properties of apigenin via targeting different molecular signatures: A Review.

Molecular biology reports·2026
Same author

Multicenter, Randomized, Phase II Trial of Olaparib Plus Radium-223 Versus Radium-223 in Men With Castration-Resistant Prostate Cancer With Bone Metastases (COMRADE).

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Recent research on germ cell tumors reveals complex pathogenesis and evolving treatments. Ongoing studies in epidemiology and molecular biology aim to improve management strategies for these cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epidemiology

Background:

  • Germ cell tumors (GCTs) exhibit significant geographic and ethnic distribution variations.
  • Incidence rates of seminoma versus nonseminoma GCTs are changing in the general population.
  • Identification of risk factors for GCT development is an active area of research.

Purpose of the Study:

  • To provide an overview of recent preclinical and clinical advancements in the field of germ cell tumors.
  • To summarize emerging data on GCT pathogenesis, risk factors, and diagnostic markers.
  • To review current and evolving treatment modalities for GCT management.

Main Methods:

  • Review of recent epidemiological studies on GCT distribution and incidence.
  • Analysis of gene and protein expression profiling for molecular insights into GCTs.

Related Experiment Videos

  • Evaluation of emerging data on diagnostic tools and treatment efficacy for GCTs.

    • Main Results:

    • Epidemiological studies show variations in GCT distribution and incidence.
    • Molecular profiling is identifying factors related to germ cell pluripotency and GCT subtypes.
    • Research is ongoing for novel tumor markers and the role of traditional markers in predicting treatment outcomes.
    • Positron emission tomography (PET) shows promise in evaluating residual seminoma lesions.
    • Evolving data refine understanding of chemotherapy, radiation, and surgery for GCTs, including toxicity profiles.

    Conclusions:

    • Preclinical and epidemiological studies underscore the complexity of germ cell tumor pathogenesis.
    • Enhanced understanding of GCT processes is expected to drive the evolution of treatments, especially for advanced stages.